As of 2025-12-19, the Relative Valuation of Syros Pharmaceuticals Inc (SYRS) is (8,929.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.12 USD, the upside of Syros Pharmaceuticals Inc based on Relative Valuation is -7619112.1%.
The range of the Relative Valuation is (6,459.99) - (12,116.75) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.1x - 14.2x | 9.6x |
| Forward P/E multiples | 7.6x - 14.9x | 11.2x |
| Fair Price | (6,459.99) - (12,116.75) | (8,929.48) |
| Upside | -5512036.0% - -10338625.5% | -7619112.1% |
| Date | P/E |
| 2025-12-17 | -0.00 |
| 2025-12-16 | -0.00 |
| 2025-12-15 | -0.00 |
| 2025-12-12 | -0.00 |
| 2025-12-11 | -0.00 |
| 2025-12-10 | -0.00 |
| 2025-12-09 | -0.00 |
| 2025-12-08 | -0.00 |
| 2025-12-05 | -0.00 |
| 2025-12-04 | -0.00 |
| 2025-12-03 | -0.00 |
| 2025-12-02 | -0.00 |
| 2025-12-01 | -0.00 |
| 2025-11-28 | -0.00 |
| 2025-11-26 | -0.00 |
| 2025-11-25 | -0.00 |
| 2025-11-24 | -0.00 |
| 2025-11-21 | -0.00 |
| 2025-11-20 | -0.00 |
| 2025-11-19 | -0.00 |
| 2025-11-18 | -0.00 |
| 2025-11-17 | -0.00 |
| 2025-11-14 | -0.00 |
| 2025-11-13 | -0.00 |
| 2025-11-12 | -0.00 |
| 2025-11-11 | -0.00 |
| 2025-11-10 | -0.00 |
| 2025-11-07 | -0.00 |
| 2025-11-06 | -0.00 |
| 2025-11-05 | -0.00 |
| 2025-11-04 | -0.00 |
| 2025-11-03 | -0.00 |
| 2025-10-31 | -0.00 |
| 2025-10-30 | -0.00 |
| 2025-10-29 | -0.00 |
| 2025-10-28 | -0.00 |
| 2025-10-27 | -0.00 |
| 2025-10-24 | -0.00 |
| 2025-10-23 | -0.00 |
| 2025-10-22 | -0.00 |
| 2025-10-21 | -0.00 |
| 2025-10-20 | -0.00 |
| 2025-10-17 | -0.00 |
| 2025-10-16 | -0.00 |
| 2025-10-15 | -0.00 |
| 2025-10-14 | -0.00 |
| 2025-10-13 | -0.00 |
| 2025-10-10 | -0.00 |
| 2025-10-09 | -0.00 |
| 2025-10-08 | -0.00 |